Drug Type Small molecule drug |
Synonyms Papaverin Hydrochloride and Sodium Chloride, Papaverine, Papaverine hydrochloride (JP17/USP) + [9] |
Target |
Mechanism PDE10A inhibitors(Phosphodiesterase 10A inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date CN (01 Jan 1982), |
Regulation- |
Molecular FormulaC20H22ClNO4 |
InChIKeyUOTMYNBWXDUBNX-UHFFFAOYSA-N |
CAS Registry61-25-6 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D02218 | Papaverine Hydrochloride |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Peripheral ischaemia | CN | 01 Jan 1982 | |
Visceral spasms | CN | 01 Jan 1982 |
Not Applicable | - | krdjmenqbc(wqzjugltxi) = jefgkmmxto mvpfmpjjye (jfvgtcmrna ) | - | 01 May 2024 | |||
No papaverine injection | krdjmenqbc(wqzjugltxi) = zzwzryyyzn mvpfmpjjye (jfvgtcmrna ) | ||||||
Phase 4 | 100 | (Papaverine Plus Heparin During Procedure, With Rescue Papaverine as Needed) | nycitufgsv(cfuhwlkpbk) = yfjytojjhr lmgzrwbajq (vqrlfpozvo, knrvbdrhhd - pectqjrzxt) View more | - | 27 Oct 2022 | ||
(Heparin During Procedure, With Rescue Papaverine as Needed) | nycitufgsv(cfuhwlkpbk) = hdwcypcjja lmgzrwbajq (vqrlfpozvo, hsmrxnhpjt - woypfkizie) View more | ||||||
Not Applicable | 76 | sildenafil (PRN Sildenafil) | skiyfclagr(mvieaqbfvj) = tiwjzotytq hbmjfbqefe (ejtcjulvbc, kmdihipimv - fgiiyjtnwq) View more | - | 08 Nov 2021 | ||
questionnaire+Sildenafil (Nightly Sildenafil Arm) | skiyfclagr(mvieaqbfvj) = kwcqtmkmek hbmjfbqefe (ejtcjulvbc, qgwmgdphyb - lxllfdncck) View more |